| CCL5, CXCL10 and CXCL11 chemokines in patients with active and stable relapsing-remitting multiple sclerosis. | |
| | |
MedLine Citation:
|
PMID: 20720435 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
OBJECTIVE: Chemokines are involved in the migration of inflammatory cells to the central nervous system in multiple sclerosis (MS). The aim of our study was to estimate the concentrations of CCL5, CXCL10 and CXCL11 in serum and cerebrospinal fluid (CSF) samples of relapsing-remitting MS (RRMS) patients during both relapse and stable disease, and to compare the results with those of controls. We also decided to evaluate the effect of methylprednisolone (MP) therapy on CCL5, CXCL10 and CXCL11 serum concentrations in MS patients with relapse. METHODS: The study groups consisted of 17 RRMS patients during relapse, 30 RRMS patients in remission and 25 patients with tension headache with no symptoms of inflammatory disease as controls. In the group of relapsing MS patients, blood samples were obtained before steroid therapy and after a 5-day treatment with MP at a dose of 1 g i.v. once daily. Chemokine levels were measured by ELISA. RESULTS: CXCL10 levels were significantly higher in the CSF of MS patients both during relapse (mean ± SD, 298.2 ± 143.8 pg/ml) and stable disease (323.7 ± 183 pg/ml) in comparison with the control group (152.4 ± 97.7 pg/ml; p < 0.001). CSF levels of CCL5 were significantly higher in relapsing MS patients (8.74 ± 6.18 pg/ml) in comparison with stable MS patients (4.4 ± 3.9 pg/ml, p = 0.005). CXCL11 levels of MS patients did not significantly differ from control values. There was no effect of MP therapy on serum levels of CCL5, CXCL10 and CXCL11. CONCLUSIONS: These observations suggest involvement of CXCL10 and CCL5 but not CXCL11 in the pathogenesis of MS. CCL5 may induce the recruitment of inflammatory cells in acute-stage MS. |
| | |
Authors:
|
Adam Szczuciński; Jacek Losy |
Related Documents
:
|
6485745 - Lymphocytapheresis therapy in multiple sclerosis, a preliminary study. 19482865 - Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis. 3302115 - Lysosomal hydrolases in cerebrospinal fluid of multiple sclerosis patients. a follow-up... 7175205 - Gm allotypes and multiple sclerosis. 15028365 - Cardiovascular risk reduction in hypertensive black patients with left ventricular hype... 2983175 - Cytomegalovirus infection in the normal host. |
Publication Detail:
|
Type: Journal Article Date: 2010-08-19 |
Journal Detail:
|
Title: Neuroimmunomodulation Volume: 18 ISSN: 1423-0216 ISO Abbreviation: Neuroimmunomodulation Publication Date: 2011 |
Date Detail:
|
Created Date: 2010-09-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9422763 Medline TA: Neuroimmunomodulation Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 67-72 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 S. Karger AG, Basel. |
Affiliation:
|
Department of Clinical Neurology, Szpital Kliniczny im. H. Siecickiego Uniwersytetu Medycznego w Poznaniu, Poznań, Poland. adamszczucinski@poczta.onet.pl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Expression of novel podocyte-associated proteins sult1b1 and ankrd25.
Next Document: Integrin ?1 subunit signaling is involved in the directed migration of human retinal pigment epithel...